Betaferon/Betaseron

DRUG2 trials

Sponsors

Bayer

Conditions

Multiple Sclerosis, Relapsing-RemittingRelapsing-remitting Multiple Sclerosis

Phase 4

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS

CompletedNCT00206648

BayerMultiple Sclerosis, Relapsing-Remitting

Start: 2003-03-31End: 2005-10-31Updated: 2014-12-31

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

CompletedNCT00317941

BayerRelapsing-remitting Multiple Sclerosis

Start: 2006-03-31End: 2008-04-30Updated: 2013-10-21